Pyörälä K, Pedersen TR, Kjekshus J, Faergemann O, Olsson AG, Thorgeirsson G: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care. 1997, 20: 614-620.
Article
PubMed
Google Scholar
Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnols JMO, Wun CC, David BR, Braunwald E, for the Cholesterol and Recurrent Events Investigators: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996, 335: 1001-1009. 10.1056/NEJM199610033351401.
Article
CAS
PubMed
Google Scholar
Rubins HB, Sander JR, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med. 1999, 341: 410-418. 10.1056/NEJM199908053410604.
Article
CAS
PubMed
Google Scholar
Diabetes Atherosclerosis Intervention Study Investigators: Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the diabetes atherosclerosis intervention study, a randomised study. Lancet. 2001, 357: 905-910. 10.1016/S0140-6736(00)04209-4.
Article
Google Scholar
Albertini JP, Valensi P, Lormeau B, Aurousseau MH, Ferrière F, Attali JR, Gattegno LG: Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Diabetes Care. 1998, 6: 1008-1013.
Article
Google Scholar
Abe Y, El-Masri B, Kimball KT, Pownall H, Reilly CF, Osmundsen K, Smith CW, Ballantyne CM: Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Throm Vasc Biol. 1998, 18: 723-731.
Article
CAS
Google Scholar
Hackman A, Abe Y, Insull W, Pownall H, Smith L, Dunn K, Gotto AM, Ballantyne CM: Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation. 1996, 93: 1334-1338.
Article
CAS
PubMed
Google Scholar
Calabresi L, Gomaraschi M, Villa B, Omoboni L, Dmitrieff C, Franeschini G: Elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterol. Arterioscler Thromb Vasc Biol. 2002, 22: 656-661. 10.1161/hq0402.105901.
Article
CAS
PubMed
Google Scholar
Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J: Plasma concentrations of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 1998, 351: 88-92. 10.1016/S0140-6736(97)09032-6.
Article
CAS
PubMed
Google Scholar
Jager A, van Hinsbergh VWM, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CDA: Increased levels of vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes. Diabetes. 2000, 49: 485-491.
Article
CAS
PubMed
Google Scholar
Gearing AJH, Newman W: Circulating adhesion molecules in disease. Immunol Today. 1993, 14: 506-512. 10.1016/0167-5699(93)90267-O.
Article
CAS
PubMed
Google Scholar
Sbarouni E, Kroupis C, Kyriakides ZS, Koniavitou K, Kremastinos : Cell adhesion molecules in relation to simvastatin and hormone replacement in coronary heart disease. Eur Heart J. 2000, 21: 975-980. 10.1053/euhj.1999.1988.
Article
CAS
PubMed
Google Scholar
Jilma B, Joukhadar C, Derhaschnig U, Rassoul F, Richter V, Wolzt I, Dorner GT, Petternel V, Wagner OF: Levels of adhesion molecules do not decrease after three months of therapy in moderate hypercholesterolemia. Clin Sci (Lond). 2003, 104: 189-193. 10.1042/CS20020168.
Article
CAS
Google Scholar
Kowalski J, Okopien B, Madej A, Zielinski M, Belowski D, Kalina Z, Herman ZS: Effects of fenofibrate and simvastatin on plasma ICAM-1 and MCP-1 conventrations in patients with hyperlipoproteinemia. Int J Clin Pharmacol Ther. 2003, 41: 241-247.
Article
CAS
PubMed
Google Scholar
Dalla Nora E, Passaro A, Zamboni PF, Calzoni F, Fellin R, Solini A: Atorvastatin improves metabolic control and endothelial function in type 2 diabetic patients: a placebo-controlled study. J Endocrinol Invest. 2003, 26: 73-78.
Article
CAS
PubMed
Google Scholar
Frost RJA, Otto C, Geiss HC, Schwandt P, Parhofer KG: Effects of atorvastatin versus fenofibrate on lipoprotein profiles, LDL subfraction distribution and hemorrheological parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia. Am J Cardiol. 2001, 87: 44-48. 10.1016/S0002-9149(00)01270-4.
Article
CAS
PubMed
Google Scholar
Kleinbaum DG, Kupper LL, Nuller KE, Nizam A: Applied regression analysis and other multivariable methods. 1998, Pacific Grove: CA, USA, 3
Google Scholar
Lupatelli G, Marchesi S, Lombardini R, Siepi D, Bagaglia F, Pirro M, Ciufetti G, Schilacci G, Mannarino E: Mechanisms of high-density cholesterol effects on endothelial function in hyperlipemia. Metabolism. 2003, 52: 1191-1195. 10.1016/S0026-0495(03)00157-4.
Article
Google Scholar
Cominacini L, Garbin U, Pasini AF, Campagnola M, Davoli A, Foot E, Sighieri G, Sironi AM, Lo Cascio V, Ferranini E: Troglitazone reduces LDL oxidation and reduces E-selectin concentrations in NIDDM patients. Diabetes. 1998, 47: 130-133.
Article
CAS
PubMed
Google Scholar
Tribble DL, Holl LG, Wood PD, Krauss RM: Variations in oxidative susceptibility among 6 low density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 1992, 93: 189-199.
Article
CAS
PubMed
Google Scholar
Zhu Y, Liao HL, Lin JHC, Verna L, Stemerman MB: Low-density lipoprotein augments interleukin-1-induced vascular adhesion molecule expression in human endothelial cells. Atherosclerosis. 1999, 44: 357-365. 10.1016/S0021-9150(99)00005-2.
Article
Google Scholar
Vaughan CJ, Murphy MB, Buckley BM: Statins do more than just lower cholesterol. Lancet. 1996, 348: 1079-1082. 10.1016/S0140-6736(96)05190-2.
Article
CAS
PubMed
Google Scholar
Bellosta S, Bernini F, Ferri N, Quarato P, Canavesi M, Arnaboldi L, Fumagalli R, Paoletti R, Corsini A: Direct vascular effects of HMG-CoA reductase inhibitors. Atherosclerosis. 1998, 137: S101-S109. 10.1016/S0021-9150(97)00319-5.
Article
CAS
PubMed
Google Scholar
Simons LA, Sullivan D, Simons J, Celermajer DS:Effects of atorvastatin and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolemia.Atherosclerosis. 1998, 137: 197-203. 10.1016/S0021-9150(97)00252-9.
Article
CAS
PubMed
Google Scholar
Capell WH, DeSouza CA, Poirier P, Bell ML, Stauffer BL, Weil KM, Hernandez TL, Eckel RH: Short-term triglyceride lowering with fenofibrate improves vascular function in subjects with hypertriglyceridemia. Arterioscl Thromb Vasc Biol. 2003, 23: 307-313. 10.1161/01.ATV.0000046230.02211.B4.
Article
CAS
PubMed
Google Scholar
Schalkwijk CG, Smulders RA, Lambert J, Donker AJ, Stehouwer CD: ACE-inhibition modulates some endothelial functions in healthy subjects and in normotensive type 1 diabetic patients. Eur J Clin Invest. 2000, 30: 853-860. 10.1046/j.1365-2362.2000.00721.x.
Article
CAS
PubMed
Google Scholar
Gasic S, Wagner OF, Fasching P, Ludwig C, Veitl M, Kapiotis S, Jilma B: Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria. Am J Hypertens. 1999, 12: 217-222. 10.1016/S0895-7061(98)00229-5.
Article
CAS
PubMed
Google Scholar